2006 and Earlier Publications

/2006 and Earlier Publications
2006 and Earlier Publications 2013-11-26T15:16:28+00:00

[av_textblock ]

1A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmissionTaha TE, Brown ER, Hoffman IF, Fawzi W, Read JS, Sinkala M, Martinson FE, Kafulafula G, Msamanga G, Emel L, Adeniyi-Jones S, Goldenberg RL2006
2Correlates of syphilis seroreactivity among pregnant women: the HIVNET 024 trial in Malawi, Tanzania, and ZambiaPotter D, Goldenberg RL, Read JS, Hoffman IF, Saathoff E, Kafulafula G, Aboud S, Martinson FE, Dahab M, Vermund SH2006
3Field validation of a thin-layer chromatography assay for detection of nevirapine in umbilical cord bloodChi BH, Lee A, Acosta EP, Westerman LE, Sinkala M, Stringer JSA2006
4HIVCorps: using volunteers to rapidly expand HIV health services across Zambia; Am J Trop Med Hyg 2006; 74: 918-21Chi BH, Fusco H, Goma FM, Zulu I, Simmers E, Stringer JSA2006
5HPTN 024 study: histologic chorioamnionitis, antibiotics, and adverse infant outcomes in a predominantly HIV-1-infected African populationGoldenberg RL, Mudenda V, Read JS, Brown ER, Sinkala M, Kamiza S, Martinson F, Kaaya E, Hoffman I, Fawzi W, Valentine M, Taha TE2006
6Individual-level predictors for HIV testing among antenatal attendees in Lusaka, ZambiaThierman S, Chi BH, Levy JW, Sinkala M, Goldenberg RL, Stringer JSA2006
7Meeting retention challenges in Lusaka, ZambiaBrahmi A, Reid C, Masse B, Kelly C2006
8Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, ZambiaParham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, Stringer EM, Vermund SH2006
9Rapid scale-up of antiretroviral therapy at primary care sites in Lusaka, Zambia: feasibility and early outcomesStringer JSA, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, Mtonga V, Reid S, Cantrell RA, Bulterys M, Saag MS, Marlink RG, Mwinga A, Ellerbrock TV, Sinkala M2006
10The HPTN 024 Study: the efficacy of antibiotics to prevent chorioamnionitis and preterm birthGoldenberg RL, Mwatha A, Read JS, Adeniyi-Jones S, Sinkala M, Msmanga G, Martinson F, Hoffman I, Fawzi W, Valentine M, Emel L, Brown E, Mudenda V, Taha TE2006

1Acute and chronic chorioamnionitis and the risk of perinatal HIV-1 transmissionChi BH, Mudenda V, Levy J, Sinkala M, Goldenberg RL, Stringer JSA2005
2Cost and enrollment implications of targeting different source population for an HIV treatment programChi BH, Fusco H, Sinkala M, Goldenberg RL, Stringer, JSA2005
3Effectiveness of a city-wide program to prevent mother-to-child HIV transmission in Lusaka, ZambiaStringer JSA, Sinkala M, Maclean CC, Levy J, Kankasa C, DeGroot A, Stringer EM, Acosta EP, Goldenberg RL, Vermund SH2005
4Employment of off-duty staff: a strategy to meet the human resource of a large PMTCT program in ZambiaChi BH, Sinkala M, Stringer EM, McFarlane YA, Ng’uni C, Myzece E, Goldenberg RL, Stringer JSA2005
5Potential cost-effectiveness of maternal and infant antiretroviral interventions to prevent mother-to-child transmission during breast-feedingMaclean CC, Stringer JSA2005
6Prevalence and predicators of intestinal helminth infections among human immunodeficiency virus type 1-infected adults in an urban African settingModjarrad K, Zulu I, Redden DT, Njobvu L, Freedman DO, Vermund SH2005
7Timing of maternal and neonatal dosing of nevirapine and the risk of mother-to-child transmission of HIV-1: HIVNET 024; AIDS 2005; 19: 1857-1864Chi BH, Wang L, Read JS, Sheriff M, Fiscus S, Brown E, Valentine M, Goldenberg RL2005
8Treatment of intestinal helminths does not reduce plasma concentrations of HIV-1 RNA in coinfected Zambian adultsModjarrad K, Zulu I, Redden DT, Njobvu L, Lane HC, Bentwich Z, Vermund SH2005

1An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 yearsBiggio JR Jr, Morris TC, Owen J, Stringer JSA2004
2Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosyReid SE, Reid CA, Vermund SH2004
3Detection of nevirapine in plasma using thin-layer chromatographyDubuisson JG, King JR, Stringer JSA, Turner ML, Bennetto C, Acosta EP2004
4Effects of concentration and temperature on the stability of nevirapine in whole blood and serumBennetto CJ, King JR, Turner ML, Stringer JSA, Acosta EP2004
5Perceptions toward HIV, HIV screening, and the use of antiretroviral medications: a survey of maternity-based healthcare providers in ZambiaChi BH, Chansa K, Gardner MO, Sangi-Haghpeykar H, Goldenberg RL, Sinkala M, Muchimba M, Stringer JSA2004
6Personal risk perception, HIV knowledge, and risk avoidance behavior, and their relationships to actual HIV serostatus in an urban African obstetric populationStringer EM, Sinkala M, Kumwenda R, Chapman V, Mwale A, Vermund SH, Goldenberg RL, Stringer JSA2004
7Prevention of mother-to-child transmission of HIV in AfricaVermund SH2004
8Prevention of pediatric human immunodeficiency virusWilfert CM, Stringer JSA2004
9Priorities for antiretroviral therapy research in sub-Saharan Africa: A 2002 Consensus Conference in ZambiaZulu I, Schuman P, Musonda R, Chomba E, Mwinga K, Sinkala M, Chisembele M, Mwaba P, Kasonde D, Vermund SH2004
10Rapid testing strategies for HIV-1 serodiagnosis in high-prevalence African settingsWright RJ, Stringer JSA2004
11Universal nevirapine upon presentation in labor to prevent mother-to-child HIV transmission in high prevalence settingsStringer JSA, Sinkala M, Goldenberg RL, Kumwenda R, Acosta EP, Aldrovandi GM, Stout JP, Vermund SH2004

1A cost-effectiveness analysis of management strategies for cervical intraepithelial neoplasia grades 2 and 3Kleinberg MJ, Straughn JM Jr, Stringer JSA, Partridge EE2003
2Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission in high-prevalence, resource-poor settings; J Acquir Immune Defic Syndr 2003, 32: 506-513Stringer JSA, Sinkala M, Stout JP, Goldenberg RL, Acosta EP, Chapman V, Kumwenda R, Vermund SH2003
3Design of the HIV Prevention Trials Network (HPTN) Protocol 054: A cluster randomized crossover trial to evaluate combined access to Nevirapine in developing countriesHughes JP, Goldenberg RL, Wilfert C, Valentine M, Mwinga K, Guay L, Mmiro F, Stringer JSA2003
4Monitoring nevirapine-based programmes for prevention of mother-to-child transmission of HIV-1Stringer JSA, Sinkala M, Goldenberg R, Vermund S, Acosta E2003
5Nevirapine to prevent mother-to-child transmission of HIV-1 among women of unknown serostatusStringer JSA, Rouse DJ, Sinkala M, Marseille EA, Vermund SH, Stringer EM, Goldenberg RL2003
6Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, ZambiaStringer EM, Sinkala M, Stringer JSA, Mzyece E, Makuka I, Goldenberg RL, Kwape P, Chilufya M, Vermund SH2003
7Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapineStringer JSA, Sinkala M, Chapman V, Acosta EP, Goldenberg RL, Stout JP, Vermund SH2003

1Effect of nevirapine toxicity on choice of perinatal HIV prevention strategiesStringer JSA, Sinkala M, Rouse DJ, Goldenberg RL, Vermund SH2002
2Perinatal HIV transmission: developing country considerationsGoldenberg RL, Stringer JSA, Sinkala M, Vermund SH2002

1Evaluation of a new testing policy for human immunodeficiency virus to improve screening ratesStringer EM, Stringer JSA, Cliver SP, Goldenberg RL, Goepfert AR2001
2Zambian women’s attitudes toward mass nevirapine therapy to prevent perinatal transmission of HIVSinkala M, Stout JP, Vermund SH, Goldenberg RL, Stringer JSA2001

1An appraisal of screening for maternal type-specific herpes simplex virus antibodies to prevent neonatal herpesRouse DJ, Stringer JSA2000
2Antiretroviral treatment was more cost-effective than formula feeding for prevention of HIV transmission: Commentary on the Analysis of Söderlund et alStringer JSA2000
3Cost-effective use of perinatal nevirapine to prevent vertical HIV transmission in sub-Saharan AfricaStringer JSA, Rouse DJ, Goldenberg RL, Vermund SH, Stinnett AA2000
4Delayed pushing in labour [Invited]Sinkala M, Stringer JSA2000
5Nevirapine prevented mother-to-child transmission of HIV-1 more effectively than zidovudine: Commentary on the Analysis of Guay et alStringer JSA2000
6Selected topics from the 13th International AIDS Conference, July 9-14, 2000Stringer JSA, Youle M, Sabin C, Chaisson RE, Sterling TR2000
7Subclinical chorioamnionitis as a targetable risk factor for perinatal transmission of HIV-1Stringer JSA, Goldenberg RL2000

1Prevention of mother-to-child transmission of HIV-1Stringer JSA, Vermund SH1999
2Prophylactic cesarean for the prevention of perinatal HIV transmission: the case for restraintStringer JSA, Rouse DJ, Goldenberg RL1999
3Rapid testing and zidovudine treatment to prevent vertical transmission of Human Immunodeficiency Virus in unregistered parturients: a cost-effectiveness analysisStringer JSA, Rouse DJ1999